Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma

被引：0
|
作者：
Kevin B. Kim
Wen-Jen Hwu
Nicholas E. Papadopoulos
Agop Y. Bedikian
Luis H. Camacho
Chaan Ng
Ingrid M. Hernandez
Angela M. Frost
Monica A. Jack
Patrick Hwu
机构：
[1] The University of Texas M. D. Anderson Cancer Center,Department of Melanoma Medical Oncology, Unit 430
[2] The University of Texas M. D. Anderson Cancer Center,Department of Diagnostic Radiology
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Phase I; Melanoma; Chemotherapy; Docetaxel; Temozolomide; Cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：161 / 167
页数：6
相关论文
共 50 条
  • [1] PHASE I STUDY OF THE COMBINATION OF DOCETAXEL, TEMOZOLOMIDE AND CISPLATIN IN PATIENTS WITH METASTATIC MELANOMA
    Kim, K. B.
    Hwu, W. J.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Camacho, L. H.
    Ng, C.
    Hernandez, I.
    Frost, A. M.
    Jack, M.
    Hwu, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 246 - 246
  • [2] Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
    Kim, Kevin B.
    Hwu, Wen-Jen
    Papadopoulos, Nicholas E.
    Bedikian, Agop Y.
    Camacho, Luis H.
    Ng, Chaan
    Hernandez, Ingrid M.
    Frost, Angela M.
    Jack, Monica A.
    Hwu, Patrick
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 161 - 167
  • [3] Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial
    Tas, F
    Argon, A
    Camlica, H
    Topuz, E
    MELANOMA RESEARCH, 2005, 15 (06) : 543 - 548
  • [4] A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma
    McQuade, Jennifer L.
    Posada, Liberty P.
    Lecagoonporn, Srisuda
    Cain, Suzanne
    Bassett, Roland L., Jr.
    Patel, Sapna P.
    Hwu, Wen-Jen
    Hwu, Patrick
    Davies, Michael A.
    Bedikian, Agop Y.
    Amaria, Rodabe N.
    MELANOMA RESEARCH, 2016, 26 (06) : 604 - 608
  • [5] A Phase I study of temozolomide and carboplatin in patients with metastatic melanoma
    Strauss, SJ
    Marples, M
    Meyer, T
    Napier, M
    Boxall, J
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2001, 85 : 51 - 51
  • [6] A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma
    Pettijohn, Erin
    Martone, Brenda
    Rademaker, Alfred
    Kuzel, Timothy
    JOURNAL OF PERSONALIZED MEDICINE, 2014, 4 (04) : 448 - 458
  • [7] Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial
    Wierzbicka-Hainaut, Ewa
    Sassolas, Bruno
    Mourey, Laurent
    Guillot, Bernard
    Bedane, Christophe
    Guillet, Gerard
    Tourani, Jean Marc
    MELANOMA RESEARCH, 2010, 20 (02) : 141 - 146
  • [8] Phase I/II study of the combination of decitabine (DAC) and temozolomide (TMZ) in patients (pts) with metastatic melanoma (MM)
    Tawbi, H. A.
    Beumer, J. H.
    Tarhini, A. A.
    Moschos, S. J.
    Egorin, M. J.
    Buch, S. C.
    Lin, Y.
    Kirkwood, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] A phase I study of high-dose calcitriol in combination with temozolomide for patients (Pts) with metastatic melanoma (MM)
    Pettijohn, Erin
    Rademaker, Alfred
    Martone, Brenda K.
    Poast, Erica
    Weitner, Bing Bing
    Eklund, John W.
    Kuzel, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Phase II study of the frontline combination of ipilimumab and temozolomide in patients with metastatic melanoma.
    Patel, Sapna Pradyuman
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Hwu, Patrick
    Radvanyi, Laszlo George
    Mahoney, Sandy
    Deburr, Tawania L.
    Liu, Ping
    Bedikian, Agop Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345